NOV (NOV)
(Delayed Data from NYSE)
$16.59 USD
+0.18 (1.10%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $16.59 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$16.59 USD
+0.18 (1.10%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $16.59 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Zacks News
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Nov Inc. (NOV) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Nov Inc. (NOV) is a Top-Ranked Growth Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Is First Trust Energy AlphaDEX ETF (FXN) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXN
Here's Why Nov Inc. (NOV) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Should You Invest in the First Trust Energy AlphaDEX ETF (FXN)?
by Zacks Equity Research
Sector ETF report for FXN
Here's Why Nov Inc. (NOV) is a Strong Growth Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Nov Inc. (NOV) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Nov Inc. (NOV) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
NOV Q2 Earnings Surpass Estimates, Revenues Increase Y/Y
by Zacks Equity Research
NOV expects a flat or low single-digit revenue growth year over year, with adjusted EBITDA between $270 million and $305 million for the third quarter of 2024.
Nov Inc. (NOV) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Nov Inc. (NOV) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Nov Inc. (NOV) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Nov Inc. (NOV) delivered earnings and revenue surprises of 62.86% and 1.98%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Factors You Need to Know Ahead of NOV Q2 Earnings Release
by Zacks Equity Research
NOV is anticipated to have generated higher revenues from the year-ago period's level. However, it is expected to have recorded a lower bottom line due to rising costs.
Climb Global (CLMB) Moves 8.5% Higher: Will This Strength Last?
by Zacks Equity Research
Climb Global (CLMB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Is NOV (NOV) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Nov Inc. (NOV) is a Top-Ranked Value Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Nov Inc. (NOV) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is John Hancock Multifactor Small Cap ETF (JHSC) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for JHSC
Should John Hancock Multifactor Small Cap ETF (JHSC) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JHSC
Here's Why Nov Inc. (NOV) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
NOV Q1 Earnings Surpass Estimates, Revenues Increase Y/Y
by Zacks Equity Research
NOV expects consolidated revenues to grow in the mid-single percentage range, with adjusted EBITDA in the range of $1.10-$1.25 billion, for full year 2024.
Nov Inc. (NOV) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Nov Inc. (NOV) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Nov Inc. (NOV) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Nov Inc. (NOV) delivered earnings and revenue surprises of 11.11% and 2.37%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?